Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

908 Devices

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

What do you view as the most disruptive or transformational technology or development on the horizon?

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

PAO-01-23-RT-01January 31, 2023

Bringing Mass Spectrometry out of the Lab and to the Point of Need

Miniaturized Mass Spectrometry

Bringing Mass Spectrometry out of the Lab and to the Point of Need

Kevin J. Knopp, Ph.D.

PAO-09-022-CL-10September 27, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

O-06-022--RT-01June 24, 2022

Q: What’s the key to being a leader in the industry?

Leadership

Q: What’s the key to being a leader in the industry?

Pharma's Almanac

PAO-03-022-RT-02March 11, 2022

Q: What important company milestone do you anticipate reaching in 2022?

Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

PAO-03-022-RT-01March 11, 2022